Stay updated on NasoVAX Extension Safety and Immunogenicity Clinical Trial

Sign up to get notified when there's something new on the NasoVAX Extension Safety and Immunogenicity Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the NasoVAX Extension Safety and Immunogenicity Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.
    Difference
    3%
    Check dated 2025-05-29T05:41:32.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    31 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.
    Difference
    0.2%
    Check dated 2025-04-30T13:57:15.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    The page has undergone significant changes, including the removal of detailed descriptions of a study related to NasoVAX and the addition of a new revision number. The principal investigator's name has also been included.
    Difference
    19%
    Check dated 2025-04-16T02:11:11.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.2%
    Check dated 2025-04-08T23:45:11.000Z thumbnail image
  7. Check
    89 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    2%
    Check dated 2025-03-03T22:19:52.000Z thumbnail image
  8. Check
    110 days ago
    Change Detected
    Summary
    The page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with a contact email for assistance.
    Difference
    3%
    Check dated 2025-02-10T09:53:52.000Z thumbnail image

Stay in the know with updates to NasoVAX Extension Safety and Immunogenicity Clinical Trial

Enter your email address, and we'll notify you when there's something new on the NasoVAX Extension Safety and Immunogenicity Clinical Trial page.